Home › Entities › business › Halozyme Therapeutics

Halozyme Therapeutics

Legal entity — legal form XTIQ, registered in US-DE
Organization business Q5643474
Press Enter · cited answer in seconds

Financials

Self-reported XBRL data from 17 annual filings
Revenue
$1.40B
▲ 37.6% YoY FY2025
Net Income
$316.89M
▼ 28.6% YoY FY2025
Assets
$2.53B
▲ 22.4% YoY FY2025
EPS (diluted)
$2.56
▼ 25.4% YoY FY2025
$0.00$384.07M$768.14M$1.15B$1.54B FY2009: $13.67M · NI -$58.36M (-426.9% margin)FY2010: $13.62M · NI -$53.24M (-390.8% margin)FY2011: $56.09M · NI -$19.77M (-35.2% margin)FY2012: $42.33M · NI -$53.55M (-126.5% margin)FY2013: $54.80M · NI -$83.48M (-152.3% margin)FY2014: $75.33M · NI -$68.38M (-90.8% margin)FY2015: $135.06M · NI -$32.23M (-23.9% margin)FY2016: $146.69M · NI -$103.02M (-70.2% margin)FY2017: $316.61M · NI $62.97M (19.9% margin)FY2018: $151.86M · NI -$80.33M (-52.9% margin)FY2019: $195.99M · NI -$72.24M (-36.9% margin)FY2020: $267.59M · NI $129.09M (48.2% margin)FY2021: $443.31M · NI $402.71M (90.8% margin)FY2022: $660.12M · NI $202.13M (30.6% margin)FY2023: $829.25M · NI $281.59M (34.0% margin)FY2024: $1.02B · NI $444.09M (43.7% margin)FY2025: $1.40B · NI $316.89M (22.7% margin) '09'11'13'15'17'19'21'23'25
■ Revenue ■ Net Income
Source: SEC EDGAR · latest 10-K filed 2025-12-31 · accession 0001159036-26-000024

Halozyme Therapeutics

Summary

Halozyme Therapeutics is a business[1].

Key Facts

  • Halozyme Therapeutics is in the country of United States[2].
  • Halozyme Therapeutics is in the country of US[3].
  • Halozyme Therapeutics's instance of is recorded as business[4].
  • Halozyme Therapeutics's instance of is recorded as public company[5].
  • Halozyme Therapeutics's headquarters location is recorded as San Diego[6].
  • Halozyme Therapeutics's stock exchange is recorded as Nasdaq[7].
  • 1998 marks the founding of Halozyme Therapeutics[8].
  • 2007-08-23 marks the founding of Halozyme Therapeutics[9].
  • Halozyme Therapeutics's official website is recorded as http://www.Halozyme.com/[10].
  • Halozyme Therapeutics's legal form is recorded as Delaware corporation[11].
  • Halozyme Therapeutics's legal form is recorded as XTIQ[12].

Product Details

The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.

GLEIF Golden Copy — Level 1 entity data

  • Legal Entity Identifier (LEI): 529900242I3SV9AGM753[13]

  • Registered legal name: Halozyme Therapeutics, INC.[14]

  • Legal jurisdiction: US-DE[15]

  • GLEIF entity category: GENERAL[16]

  • Legal form (ISO 20275 ELF): XTIQ[17]

  • Entity status: ACTIVE[18]

  • LEI registration status: ISSUED[19]

  • Entity created: 2007-08-23[20]

  • LEI first registered: 2018-11-02[21]

  • LEI last updated: 2026-03-27[22]

  • LEI next renewal: 2027-04-03[23]

  • Managing LOU: 5493001KJTIIGC8Y1R12[24]

  • Registration authority: RA000602[25]

  • Authority entity ID: 4406566[26]

  • Conformity flag: CONFORMING[27]

Body

Founding

Recorded inception include 1998[8] and 2007-08-23[9].

Operations

Halozyme Therapeutics's headquarters location is recorded as San Diego[6].

Ownership

Halozyme Therapeutics's stock exchange is recorded as Nasdaq[7].

Related Entities

business Nasdaq public company San Diego United States

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . Crunchbase. crunchbase.com. Provenance: wikidata.org.
  2. [3] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . Global LEI Index. Retrieved . wikidata.org.
  11. [12] ↑ . wikidata.org.

Product details (FDA / USDA / NHTSA public-domain catalog data)

  1. [13] ↑ . Global Legal Entity Identifier Foundation (GLEIF). Retrieved . gleif.org.
  2. [14] ↑ . Global Legal Entity Identifier Foundation (GLEIF). Retrieved . gleif.org.
  3. [15] ↑ . Global Legal Entity Identifier Foundation (GLEIF). Retrieved . gleif.org.
  4. [16] ↑ . Global Legal Entity Identifier Foundation (GLEIF). Retrieved . gleif.org.
  5. [17] ↑ . Global Legal Entity Identifier Foundation (GLEIF). Retrieved . gleif.org.
  6. [18] ↑ . Global Legal Entity Identifier Foundation (GLEIF). Retrieved . gleif.org.
  7. [19] ↑ . Global Legal Entity Identifier Foundation (GLEIF). Retrieved . gleif.org.
  8. [20] ↑ . Global Legal Entity Identifier Foundation (GLEIF). Retrieved . gleif.org.
  9. [21] ↑ . Global Legal Entity Identifier Foundation (GLEIF). Retrieved . gleif.org.
  10. [22] ↑ . Global Legal Entity Identifier Foundation (GLEIF). Retrieved . gleif.org.
  11. [23] ↑ . Global Legal Entity Identifier Foundation (GLEIF). Retrieved . gleif.org.
  12. [24] ↑ . Global Legal Entity Identifier Foundation (GLEIF). Retrieved . gleif.org.
  13. [25] ↑ . Global Legal Entity Identifier Foundation (GLEIF). Retrieved . gleif.org.
  14. [26] ↑ . Global Legal Entity Identifier Foundation (GLEIF). Retrieved . gleif.org.
  15. [27] ↑ . Global Legal Entity Identifier Foundation (GLEIF). Retrieved . gleif.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Halozyme Therapeutics. Retrieved September 1, 2026, from https://4ort.xyz/entity/halozyme-therapeutics
MLA “Halozyme Therapeutics.” 4ort.xyz Knowledge Graph, 4ort.xyz, 1 Sep. 2026, https://4ort.xyz/entity/halozyme-therapeutics.
BibTeX @misc{4ortxyz_halozyme-therapeutics_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Halozyme Therapeutics}}, year = {2026}, url = {https://4ort.xyz/entity/halozyme-therapeutics}, note = {Accessed: 2026-09-01}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Halozyme Therapeutics — https://4ort.xyz/entity/halozyme-therapeutics (retrieved 2026-09-01)

Canonical URL: https://4ort.xyz/entity/halozyme-therapeutics · Last refreshed: